New lower-dose radiotherapy trial opens at The Christie
Researchers at The Christie are looking at whether 2 de-escalated (lower doses) of targeted radiotherapy are as effective as 2 regular doses at treating men with intermediate-risk prostate cancer.
Read New lower-dose radiotherapy trial opens at The Christie Article